Aronia Berry Supplementation Mitigates Inflammation in T Cell Transfer-Induced Colitis by Decreasing Oxidative Stress by Pei, Ruisong et al.
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Nutrition Department Faculty Publication Series Nutrition 
2019 
Aronia Berry Supplementation Mitigates Inflammation in T Cell 
Transfer-Induced Colitis by Decreasing Oxidative Stress 
Ruisong Pei 
Jiyuan Liu 
Derek A. Martin 
Jonathan C. Valdez 
Justin Jeffety 
See next page for additional authors 
Follow this and additional works at: https://scholarworks.umass.edu/nutrition_faculty_pubs 
Authors 
Ruisong Pei, Jiyuan Liu, Derek A. Martin, Jonathan C. Valdez, Justin Jeffety, Gregory A. Barrett-Wilt, 
Zhenhua Liu, and Bradley W. Bolling 
nutrients
Article
Aronia Berry Supplementation Mitigates
Inflammation in T Cell Transfer-Induced Colitis by
Decreasing Oxidative Stress
Ruisong Pei 1, Jiyuan Liu 1,2, Derek A. Martin 1, Jonathan C. Valdez 1, Justin Jeffery 3,
Gregory A. Barrett-Wilt 4, Zhenhua Liu 5 and Bradley W. Bolling 1,*
1 Department of Food Science, University of Wisconsin-Madison, 1605 Linden Dr., Madison, WI 53706, USA;
ruisong.pei@wisc.edu (R.P.); jliu678@wisc.edu (J.L.); mrtn.drk@gmail.com (D.A.M.);
jcvaldez@wisc.edu (J.C.V.)
2 China Agricultural University, College of Food Science and Nutritional Engineering,
No.17 Qinghua Dong Lu, Beijing 100083, China
3 Wisconsin Institutes for Medical Research, University of Wisconsin-Madison, 1111 Highland Ave.,
Madison, WI 53706, USA; jjjeffery@wisc.edu
4 Mass Spectrometry Facility, Biotechnology Center, University of Wisconsin-Madison, 425 Henry Mall,
Madison, WI 53706, USA; barrettwilt@wisc.edu
5 University of Massachusetts, Amherst, School of Public Health and Health Sciences, 100 Holdsworth Way,
Amherst, MA 01003, USA; zliu@nutrition.umass.edu
* Correspondence: bwbolling@wisc.edu; Tel.: +1-608-890-0212; Fax: +1-608-262-6872
Received: 9 May 2019; Accepted: 10 June 2019; Published: 12 June 2019


Abstract: Oxidative stress is involved in the pathogenesis and progression of inflammatory bowel
disease. Consumption of aronia berry inhibits T cell transfer colitis, but the antioxidant mechanisms
pertinent to immune function are unclear. We hypothesized that aronia berry consumption could
inhibit inflammation by modulating the antioxidant function of immunocytes and gastrointestinal
tissues. Colitis was induced in recombinase activating gene-1 deficient (Rag1-/-) mice injected
with syngeneic CD4+CD62L+ naïve T cells. Concurrent with transfer, mice consumed either 4.5%
w/w aronia berry-supplemented or a control diet for five weeks. Aronia berry inhibited intestinal
inflammation evidenced by lower colon weight/length ratios, 2-deoxy-2-[18F]fluoro-d-glucose (FDG)
uptake, mRNA expressions of tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) in
the colon. Aronia berry also suppressed systemic inflammation evidenced by lower FDG uptake in
the spleen, liver, and lung. Colitis induced increased colon malondialdehyde (MDA), decreased colon
glutathione peroxidase (GPx) activity, reduced glutathione (rGSH) level, and suppressed expression
of antioxidant enzymes in the colon and mesenteric lymph node (MLN). Aronia berry upregulated
expression of antioxidant enzymes, prevented colitis-associated depletion of rGSH, and maintained
GPx activity. Moreover, aronia berry modulated mitochondria-specific antioxidant activity and
decreased splenic mitochondrial H2O2 production in colitic mice. Thus, aronia berry consumption
inhibits oxidative stress in the colon during T cell transfer colitis because of its multifaceted antioxidant
function in both the cytosol and mitochondria of immunocytes.
Keywords: aronia berry; adoptive transfer colitis; inflammatory bowel disease; oxidative stress
1. Introduction
Inflammatory bowel diseases (IBD) affect more than 0.3% of the population in North America,
Oceania and many European countries, and the incidence is rising rapidly in newly industrialized
countries in Africa, Asia and South America [1]. The primary therapeutics for IBD target inflammatory
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cascades and enteric microbiota [2,3]. For example, anti-tumor necrosis factor (TNF) antibody is widely
used for downregulating immune response [4]. Antibiotics might selectively decrease pathogenic
bacterial species or globally reduce bacterial population, depending on the spectrum of activity [5].
However, it has been documented that antibiotics might negatively affect the environmental conditions
of gut microbiota and cause antimicrobial resistance [6]. Consumption of probiotics and prebiotics
may increase beneficial commensal microbes such as Lactobacillus and Bifidobacterium species in the
gut, but their treatment efficacy is not well established for IBD [5,7]. Moreover, prolonged treatment
with these therapies can lead to high relapse rates, drug resistance and various adverse effects such as
gastrointestinal problems, anemia, carcinogenesis, hepatotoxicity, nephrotoxicity and hypersensitivity
reactions [6].
Recently, redox imbalance has been proposed as one potential etiologic factor for IBD [6]. Patients
with IBD have decreased antioxidant capacity and increased biomarkers for oxidative stress in the blood
relative to healthy individuals [8,9]. Oxidative stress is involved in the pathogenesis and progression
of IBD via several mechanisms: reactive oxygen species (ROS) activate the nuclear factor kappa B
(NF-κB) pathway, resulting in loss of the epithelial barrier via induction of metalloproteinases and
myosin light-chain kinase [10]; lipid oxidation products such as 4-hydroxynonenal and oxysterols
induce apoptosis of cells in the epithelial barrier [11,12]; moreover, ROS dose-dependently disrupt the
actin cytoskeleton and monolayer barrier function by increasing actin oxidation [13].
Considering the limitations of current therapies and the important role of oxidative stress in
pathogenesis and progression of IBD, various antioxidant-rich foods such as orange juice, blueberry
extract, bergamot juice and grape juice have been examined for their beneficial effects on IBD [14–17].
Aronia is a genus of shrubs containing three major cultivars namely Aronia melanocarpa, Aronia arbutifolia,
and Aronia prunifolia, while the predominant cultivar in the United States is Aronia mitschurinii ‘Viking’
which is likely hybridized from A. melanocarpa [18]. The aronia berry is rich in anthocyanins, flavonoids,
hydroxycinnamic acids, and proanthocyanidins [18]. Consumption of aronia extract increased serum
concentration of superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase in adults
with metabolic syndrome relative to an untreated control group [19]. Aronia extract supplementation
increased plasma paraoxonase and catalase activities, and hepatic GPx activity in apolipoprotein E
knockout mice [20]. Aronia extract also inhibited expressions of lipopolysaccharide (LPS)-induced
cyclooxygenase 2 (COX-2) and inducible nitric-oxide synthase (iNOS) in vitro [21].
We previously demonstrated that aronia berry consumption at a nutritionally-relevant dose
inhibited T cell transfer-induced colitis in mice by modulation of anti-inflammatory Th17 and Treg
differentiation, colonic cytokines, and cecal microbiota diversity [22]. However, it is not clear how the
antioxidant functions of aronia berry contribute to the protective mechanism in T cell transfer colitis.
We hypothesized that aronia berry consumption inhibits colitis by modulating antioxidant function
of immunocytes. Here, we present evidence that aronia berry consumption prevents depletion of
antioxidant enzymes and reduces oxidative stress in the immunocytes and tissues of mice with colitis,
which contributes to the anti-inflammatory mechanism.
2. Material and Methods
2.1. Reagents
Acetonitrile (ACN), butylated hydroxytoluene (BHT), ethylenediaminetetraacetic acid (EDTA),
ethanol, formic acid (FA), phosphate buffered saline (PBS), potassium chloride (KCl), sodium
acetate, and sodium hydroxide (NaOH) were purchased from Fisher Scientific (Pittsburgh, PA, USA).
1,1,3,3-tetramethoxypropane (TMP), 2-thiobarbituric acid (TBA), 2-vinylpyridine, metaphosphoric
acid, and trichloroacetic acid (TCA) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
(3-hydroxybenzyl) triphenylphosphonium bromide (MitoB), MitoPhenol (MitoP), d15-MitoB, and
d15-MitoP were purchased from Cayman Chemical (Ann Arbor, MI, USA). DL-Dithiothreitol (DTT)
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was purchased from Dot Scientific (Burton, MI, USA). “Viking” aronia berry was provided by Bellbrook
Berry Farm (Brooklyn, WI, USA).
2.2. Induction of Transfer Colitis and Experimental Design
Mice were obtained from the University of Wisconsin-Madison Research Animal Resource Center
which maintained colonies from breeder pairs purchased from Jackson Laboratory (Bar Harbor, ME,
USA). Mice were housed under controlled environment conditions with a 12-h light–dark cycle. All
experiments were reviewed and approved by the Institutional Animal Care and Use Committee of the
University of Wisconsin-Madison under protocol A005914-A02.
Colitis was induced by adoptive transfer as previously described [23]. Briefly, donor mice
(C57BL/6J) were euthanized at 6–8 weeks old and spleens were harvested for isolation of CD4+CD62L+
naïve T cells using a naïve T cells isolation kit (Cat # 130-106-643, Miltenyi Biotec Inc., San Diego, CA,
USA). Then, colitis was induced in C57BL/6J-background recombinase activating gene-1-deficient
(Rag1-/-) mice by transferring 5 × 105 purified CD4+CD62L+ naïve T cells intraperitoneally from gender
and age-matched donor mice. After the transfer, the mice were randomly assigned to either the
American Institute of Nutrition (AIN)-93M control diet as the colitic control group, or a modified
AIN-93M diet supplemented with 4.5% lyophilized “Viking” aronia berry powder at the expense of corn
starch (Envigo RMS, Inc., Indianapolis, IN, USA) as the aronia group. This dose is equivalent to a 70 kg
adult consuming ~1 cup of fresh aronia berries per day [24]. The aronia-supplemented diet contained
847 ± 54 nmol phenolic acid, 1440 ± 250 nmol anthocyanin, and 233 ± 17 nmol proanthocyanidins
(as (+)-catechin equivalents) per g of diet [22]. The dietary fiber content of aronia berry increased the
total fiber content from 5% in the control diet to 6% in the aronia diet [25]. Another group of Rag1-/-
mice were reconstituted with splenic CD4+ T cells (containing a wide range of regulatory, helper, and
effector T cells) isolated by a commercial kit (Cat# 130-104-454, Miltenyi Biotec Inc., San Diego, CA,
USA), serving as the non-colitic control [26]. Food intake and body weights of mice were recorded for
the duration of the experiment. Mice were euthanized at 5 weeks post transfer.
2.3. FDG Bio-Distribution
Tissue distribution of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) was determined as a biomarker for
tissue inflammation [27]. Briefly, mice were fasted 12 h prior to intravenous injection of approximately
1.85 MBq of FDG (Sofie Biosciences, Culver City, CA, USA) 1 h before sacrificing (n = 5–6 per group).
Mice were then warmed after injection and induced with inhalation anesthetic gas using 2% isoflurane
(Piramal Healthcare, Mumbai, India) mixed with 1 L/min of pure oxygen until cervical dislocation [28].
Colon, cecum, small intestine, spleen, liver, and lung were excised, wet-weighed using an XPE205
analytical scale (Mettler Toledo, Columbus, OH, USA) and then measured with a 2480 Wizard2 gamma
counter (Perkin Elmer, Waltham, MA, USA). Blood and feces were flushed from the tissues, and surgical
tools were rinsed between tissue resection to prevent cross contamination of FDG. Decay-corrected
percent injection dose per gram of tissue (%ID/gtissue) was calculated for each sample.
2.4. GPx Activity
Colon samples were rinsed with ice-cold PBS and then homogenized in 5 mL of ice-cold PBS (with
5 mM EDTA and 1 mM DTT) per g tissue with a Fisher Scientific™ Bead Mill 4 homogenizer (Pittsburgh,
PA, USA). The homogenate was then centrifuged at 10,000× g for 15 min at 4 ◦C. Supernatant aliquots
were used to measure GPx activity by an assay kit (Cayman Chemical, Ann Arbor, MI) and to determine
protein content by the Pierce™ BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA).
GPx activity was expressed as nmol/min/µg protein.
2.5. Glutathione (GSH)
GSH was measured with the 5,5′-dithio-bis-2-(nitrobenzoic acid) assay using commercial reagents
(Cayman Chemical, Ann Arbor, MI, USA) [29]. Supernatant was obtained similarly as described in
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Section 2.4, except that a PBS buffer at pH 7.0 with 1 mM EDTA was used for homogenization. Then,
the supernatant was treated with an equal volume of metaphosphoric acid (10%, m/v) and centrifuged
at 2000× g to remove interferences due to particulates and sulfhydryl groups on proteins. Half of
the deproteinated sample was further treated with 2-vinylpyridine to derivatize reduced glutathione
(rGSH) [30]. Then, the original and derivatized samples were used to determine total GSH content and
glutathione disulfide (GSSG) only, respectively. GSH level was calculated as the percentage of rGSH in
total GSH.
2.6. MitoB Treatment and Quantification
To determine the redox status in mitochondria, a ratiometric mass spectrometry probe namely
MitoB was adopted; MitoB accumulates in mitochondria and reacts with H2O2 to form MitoP and
the MitoP/MitoB ratio serves as an indicator of mitochondrial H2O2 level [31]. Briefly, mice received
25 nmol MitoB in sterile PBS by retro-orbital injection under anesthesia (n = 4–5 per group). Mice
were then kept cages for 4 h to allow MitoB to respond to mitochondrial H2O2. After that, mice were
euthanized, and the spleen and colon were harvested and cleaned with ice-cold PBS. For extraction,
40 mg of colon or spleen tissues were homogenized in 200 µL of 60% ACN/0.1% FA (v/v) in H2O with
a Fisher Scientific™ Bead Mill 4 homogenizer (Pittsburgh, PA, USA). Then, the homogenates were
spiked with 100 pmol d15-MitoB and 50 pmol d15-MitoP in 10 µL ethanol (as internal standard). Then,
the mixture was centrifuged at 16,000× g for 10 min. The supernatant was filtered with a 0.22 µm
polyvinylidene fluoride (PVDF) filter, dried with a Savant SpeedVac (Thermo Scientific, Waltham, MA,
USA) and re-dissolved in 20% ACN/0.1% FA (v/v) in H2O for LC-MS/MS analysis.
Samples were resolved on an Inertsil Ph-3 (2.1mm × 150mm, 3 µm, GL Sciences, Rolling Hills
Estates, CA, USA) using an Agilent 1100 series capillary HPLC system equipped with autosampler
(held at 6 ◦C) and column compartment (held at 30 ◦C) (Agilent Technologies, Santa Clara, CA,
USA). Solvents were A: 0.1% FA (v/v) in water, and B: 0.1% FA (v/v) in ACN running at 0.2 mL/min.
The gradient started at 5% B for 2 min, then increased to 25% B over 3 min, increased to 75% B over
5 min, increased to 100% B over 5 min, held at 100% B for 5 min, decreased to 5% B over 5 min and held
for 14 min. For mass spectrometry, a Thermo TSQ Quantum Discovery Max system (Thermo Fisher
Scientific, Waltham, MA, USA) was operated in positive ion electrospray mode. Spray voltage was
4000 V using the HESI-II source. The vaporizer temperature was 400 ◦C. The sheath gas, ion sweep
gas, and aux gas were set at 30, 0, and 1 (arbitrary units), respectively. The capillary temperature
was 350 ◦C and capillary offset was 35 V. Selected reaction monitoring (SRM) data was collected in
centroid mode with a scan width of 0.2 m/z and a scan time of 0.3 s. Collision energy was 50 V for all
analytes. Collision gas pressure was 1.5 mT. For MitoP, Q1 was 369.22 and Q3 was 183.0. For d15-mitoP
Q1 was 384.34 and Q3 was 191.1. For MitoB Q1 was 397.22 and Q3 was 183.0. For d15-mitoB Q1
was 412.34 and Q3 was 191.1. A calibration curve of standards was constructed using area under the
curve of analytes (0–50 µM for MitoB; 0–10 µM for MitoP) relative to internal standards to determine
analyte concentrations.
2.7. Colon Malondialdehyde (MDA)
MDA in the colon was extracted and measured by high-performance liquid chromatography-
fluorescence detection (HPLC-FLD) as previously described with minor modifications [32]. Briefly,
50 mg of colon was homogenized in 0.5 mL ice-cold 0.15 mol/L KCl containing 0.01% BHT using a
Fisher Scientific™ Bead Mill 4 homogenizer (Pittsburgh, PA, USA). Then, 50 µL homogenate was mixed
with 400 µL of KCl, 40 µL of 0.2% BHT in ethanol and 200 µL of 1N NaOH, and then incubated at
60 ◦C for 30 min. Then, protein was precipitated by mixing with 2 mL of 5% TCA. After centrifugation
at 1000× g for 10 min at 4 ◦C, 500 µL of supernatant was derivatized with 0.6% TBA at 95 ◦C for
30 min. Then, the sample was extracted with butanol, and injected onto a Dionex UltiMate 3000
HPLC equipped with an LPG-3400 quaternary pump, a WPS-3000 analytical autosampler, and an
FLD-3100 fluorescence detector (Thermo Fisher Scientific, San Jose, CA, USA). Samples were resolved
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isocratically at 0.8 mL/min on a Discovery® C18 column (250 × 4.6 mm, 5µm; Supelco, Bellefonte, PA,
USA) using 40:60 methanol and 25 mM potassium phosphate buffer (pH 6.5). MDA was quantified
against standards prepared in parallel from TMP and was normalized to colonic protein.
2.8. qPCR Analysis
RNA in the colon, spleen, and mesenteric lymph node (MLN) was extracted by TRIzol reagent
and further purified with a RNeasy mini kit (Qiagen, Valencia, CA, USA). After subsequent cDNA
synthesis, reverse transcription quantitative PCR (RT-qPCR) was performed using the iTaq™Universal
SYBR® Green Supermix (Bio-Rad, Hercules, CA, USA), on a Bio-Rad CFX96 system (Bio-Rad, Hercules,
CA, USA). A detailed description of the methodology and primer sequences are provided in the
Supplementary Information and Supplementary Table S1.
2.9. Statistical Analysis
All results were expressed as means ± SEMs. Statistical analysis was conducted on SAS 9.4
software (Cary, NC, USA). The significance level was set at α = 0.05 for all tests. Body weight changes
were analyzed by two-way repeated measures (RM) ANOVA (PROC MIXED) with time and treatment
group as independent variables. Multiple comparisons were conducted among groups at different
weeks with Tukey’s test. For colon weight/length, FDG uptakes, MitoP/MitoB ratio, MDA, GPx activity,
and rGSH level, significance testing was done by ANOVA with Tukey’s test for multiple comparison
(PROC GLM). The mRNA expressions of cytokines in Rag1-/- mice was assessed for significance by
the Mann–Whitney U-test (PROC NPAR1WAY). The mRNA expressions of antioxidant enzymes and
glucose transporters in Rag1-/- mice was assessed for significance by the Kruskal–Wallis test with
Dunn’s test for multiple comparison (PROC NPAR1WAY).
3. Results
3.1. Aronia Berry Inhibited Inflammation after T Cell Adoptive Transfer-Induced Colitis
Transfer of CD4+CD62L+ naïve T cells induced weight loss after five weeks in mice fed the control
diet, but aronia berry consumption significantly reduced the extent of colitic weight loss (Figure 1A).
At this time point, mice in both groups had developed severe colitis as indicated by histopathological
analysis (Supplementary Figure S1, [22]). The food intake in non-colitic, colitic, and aronia groups
did not differ at week 5 (2.90 ± 0.14 vs. 2.63 ± 0.06 vs. 2.77 ± 0.17 g/mouse/day in male mice, p > 0.05;
2.40 ± 0.10 vs. 2.46 ± 0.40 vs. 2.37 ± 0.10 g/mouse/day in female mice, p > 0.05), indicating the
supplementation of aronia powder did not change the palatability of diets. Naïve T cell transfer
increased the colon weight/length ratio by 31% of the non-colitic group, whereas the aronia group had
a similar colon weight/length ratio to the non-colitic group (Figure 1B). Colitis also increased the extent
of inflammation as measured by FDG uptake in tissues. Relative to the non-colitic control, the colitic
group had increased FDG uptake in the colon by 77%, small intestine by 50%, and spleen by 53%.
In contrast, the aronia group had similar or lower FDG uptake in the colon, cecum, small intestine,
spleen, liver, and lung compared to the non-colitic group and colitic group, indicating inhibition of
inflammation in the gastrointestinal tract and peripheral tissues (Figure 1C).
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group of Rag1-/- mice received splenic CD4+ cells, consumed AIN-93M diet, and served as the non-
colitic control. (A) Body weight changes after T cell transfer, as mean percentage of initial body weight 
at transfer (n = 9–10/group). Data bearing different letters indicate significant within-week differences 
(p < 0.05). (B) Colon weight/length ratio (n = 9–10/group). (C) Tissue 2-deoxy-2-[18F]fluoro-D-glucose 
(FDG) uptakes at 1 h after intravenous injection of approximately 1.85 MBq of FDG (n = 4–6/group). 
Groups bearing different letters indicate significant differences between treatments (p < 0.05). Data 
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both increased in the aronia group relative to the colitic control (Figure 2B). In the spleen, Tnf, Ifng, 
Il17a, and Il10 were not affected by diet (Figure 2C). Likewise, Foxp3 and Rorc, transcription factors 
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Figure 1. Consumption of 4.5% aronia berry-supplemented diet mitigates wasting induced by T cell
transfer colitis in mice. Splenic CD4+CD62L+ cells from C57BL/6J mice were transferred to Rag1-/- mice.
Mice consumed the AIN-93M diet (colitic control) or aronia-supplemented diet for five weeks. A third
group of Rag1-/- mice received splenic CD4+ cells, consumed AIN-93M diet, and served as the non-colitic
control. (A) Body weight changes after T cell transfer, as mean percentage of initial body weight at
transfer (n = 9–10/group). Data bearing different letters indicate significant within-week differences
(p < 0.05). (B) Colon weight/length ratio (n = 9–10/group). (C) Tissue 2-deoxy-2-[18F]fluoro-d-glucose
(FDG) uptakes at 1 h after intravenous injection of approximately 1.85 MBq of FDG (n = 4–6/gro p).
Groups bearing different letters indicate ignificant differences be ween treatments (p < 0.05). Data are
means ± SEMs.
3.2. Aronia Berry Downregulated mRNA Expression of Inflammatory Cytokines
Relative to the colitic control, the aronia group had 86% and 48% less mRNA expression of
tumor necrosis factor alpha (Tnf ) and interferon gamma (Ifng) in colon tissue (Figure 2A). The colonic
interleukin (IL)-6 (Il6) mRNA expression was 65% lower in the aronia group relative to the colitic
control but was not statistically significant (p = 0.07). In the MLN, IL-17A (Il17a) and IL-10 (Il10) were
both increased in the aronia group relative to the colitic control (Figure 2B). In the spleen, Tnf, Ifng,
Il17a, and Il10 were not affected by diet (Figure 2C). Likewise, Foxp3 and Rorc, transcription factors
indicative of Treg and Th17, respectively, were not altered by in the colon, MLN, or spleen by the
aronia diet.
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Figure 2. Aronia consumption downregulates mRNA expression of pro-inflammatory cytokines
and up-regulates anti-inflammatory cytokines. Splenic CD4+CD62L+ cells from C57BL/6J mice were
transferred to Rag1-/- mice. Mice consumed the AIN-93M diet (colitic control) or aronia-supplemented
diet for five weeks. A third group of Rag1-/- mice received splenic CD4+ cells, consumed AIN-93M diet
and served as the non-colitic control. The mRNA expressions of transcription factors of Foxp3 (forkhead
box P3) and Rorc (RAR-related orphan receptor gamma), and cytokines of Il17a (interleukin 17A),
Il22 (interleukin 22), Il6 (interleukin 6), Il10 (interleukin 10), Ifng (interferon-gamma), and Tnf (tumor
necrosis factors) in the (A) colon (n = 4–5/group), (B) mesenteric lymph node (MLN) (n = 8–10/group),
and (C) spleen (n = 3–5/group). The mRNA expressions were normalized to Eef2 (eukaryotic translation
elongation factor 2) and Rplp0 (ribosomal protein large P0) genes. Data are means ± SEMs.
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Figure 3. Aronia consumption reduces mitochondria H2O2. Splenic CD4+CD62L+ cells from
C57BL/6J mice were transferred to Rag1-/- mice. Mice consumed the AIN-93M diet (colitic control)
or aronia-supplemented diet for five weeks. A third group of Rag1-/- mice received splenic CD4+
cells, consumed AIN-93M diet, and served as non-colitic control. MitoP/MitoB ratio in (A) spleen and
(B) colon (n = 4–5/group). Groups bearing different letters indicate significant differences between
treatments (p < 0.05). Data are means ± SEMs.
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Figure 4. Aronia consumption reduces malondialdehyde (MDA) and prevents depletion of antioxidant
enzymes in colon. Splenic CD4+CD62L+ cells from C57BL/6J mice were transferred to Rag1-/- mice.
Mice consumed the AIN-93M diet (colitic control) or aronia-supplemented diet for five weeks. A third
group of Rag1-/- mice received splenic CD4+ cells, consumed AIN-93M diet, and served as the
non-colitic control. (A) Colon MDA (n = 4–5/group). (B) Colon glutathione peroxidase (GPx) activity
(n = 8–10/group). (C) Colon reduced glutathione (rGSH) (n = 8–10/group). Groups bearing different
letters indicate significant differences between treatments (p < 0.05). Data are means ± SEMs.
3.4. Aronia Berry Prevents Colitis-Associated Downregulation of Endogenous Antioxidant Enzymes
mRNA Expression
The expression of nuclear factor-erythroid 2-related factor-2 (Nrf2) and antioxidant enzymes in
the colon, MLN, and spleen was further evaluated to explain how aronia consumption modulates
antioxidant function in these tissues. Colitis reduced colonic Sod2, Gpx1, and Prdx1 (peroxiredoxin) by
37%, 29%, and 58%, respectively, compared to the non-colitic control (Figure 5A). Aronia consumption
normalized Sod2 and Gpx1 to the non-colitic control. In the MLN, colitis also reduced the expression of
Nrf2 (Nfe2l2), γ-glutamylcysteine synthetase (Gclc), glutathione reductase (Gsr), Gpx1, and Gpx2 by
27% to 45% relative to the non-colitic control (Figure 5B). Aronia consumption also normalized the
expression of these genes to the healthy control in the MLN. In the spleen, Nfe2l2, Gclc, Gsr, Sod2, Gpx1,
Gpx2, and Prdx1 were not consistently affected by T cell transfer colitis (Figure 5C). However, aronia
supplementation tended to increase the expression of Sod2 by 91% (p = 0.07), Gpx1 by 127% (p = 0.09),
and Prdx1 by 121% (p = 0.07).
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Figure 5. ronia consu ption aintains R expression of endogenous antioxidant enzy es.
Splenic CD4+CD62L+ cells fro C57BL/6J ice were transferred to Rag1-/- mice. ice consu ed the
AIN-93 diet (colitic control) or aronia-supplemented diet for five weeks. A third group of Rag1-/-
mice received splenic CD4+ cells, consumed AIN-93M diet, and served as the non-colitic control.
The mRNA expressions of transcription factor of Nfe2l2 (erythroid-derived 2-like 2) and the downstream
antioxidant enzymes of Gclc (glutamate-cysteine ligase-catalytic subunit), Gsr (glutathione reductase),
Sod2 (superoxide dismutase 2), Gpx1 (glutathione peroxidase 1), Gpx2 (glutathione peroxidase 2),
and Prdx1 (peroxiredoxin 1) in the (A) colon (n = 4–5/group), (B) mesenteric lymph node (MLN)
(n = 9–10/group), and (C) spleen (n = 3–5/group). Gene expression was normalized to Eef2 (eukaryotic
translation elongation factor 2) and Rplp0 (ribosomal protein large P0) genes. Bars bearing different
letters indicate significant differences between treatments (p < 0.05). Data are means ± SEMs.
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3.5. Aronia Berry Does Not Affect mRNA Expression of Glucose Transporters
Since the uptake of FDG could be limited by glucose transport, we evaluated Glut1 (glucose
transporter 1) in the colon, MLN, and spleen, and Sglt1 (sodium glucose cotransporter) in the colon
of mice. Relative to the non-colitic control, adoptive transfer colitis induced Glut1 by ~10-fold in the
colon and by ~50% in the MLN (Figure 6A). Aronia feeding did not affect Glut1 in the colon, MLN, or
spleen nor colonic Sglt1 in Rag1-/- mice that received CD4+CD62L+ naïve T cells (Figure 6B).
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aronia berry depended on different physiological states, we evaluated how aronia consumption 
affected inflammation and redox status in healthy wild type mice that were fed either the control or 
the aronia diet for five weeks. Aronia berry supplementation did not change the expressions of 
splenic inflammatory cytokines (Il17a, Il6, Il10, Tnf, Ifng) or Treg/Th17 transcription factors (Foxp3, 
Rorc), tended to decrease Gsr (p = 0.06) and Sod2 (p = 0.07), and decreased Glut1 by 17% in healthy 
mice (Figure 7A–C). Since MLN tissue is an important site of T cell differentiation and aronia feeding 
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Figure 6. Aronia berry does not affect the expression of glucose transporters in colitic mice. Splenic
CD4+CD62L+ cells from C57BL/6J mice were transferred to Rag1-/- mice. Mice consumed the AIN-93M
diet (colitic control) or aronia-supplemented diet for five weeks. A third group of Rag1-/- mice received
splenic CD4+ cells, consumed AIN-93M diet, and served as the non-colitic control. (A) Glut1 (glucose
transporter 1) in the colon (n = 4–5/group), mesenteric lymph node (MLN) (n = 9–10/group), and
spleen (n = 3–5/group). (B) Sglt1 (sodium glucose cotransporter 1) expression in colon (n = 4–5/group).
The mRNA expressions in Rag1-/- mice were normalized to Eef2 (eukaryotic translation elongation
factor 2) and Rplp0 (ribosomal protein large P0) genes. Bars bearing different letters indicate significant
differences between treatments (p < 0.05).
3.6. Aronia Berry Reduces Oxidative Stress in Healthy Wild Type Mice without Affecting Inflammatory Status
To determine whether the association between anti-inflammatory and antioxidant function of
aronia berry depended on different physiological states, we evaluated how aronia consumption
affected inflammation and edox tatus in healthy wild type ice that were fed either the control
or the ronia di t for five weeks. Aronia berry supplem ntation did not c ange the expre sions of
splenic inflam atory cytokines (Il17a, Il6, Il10, Tnf, Ifng) or Treg/T 17 transcription factors (Foxp3,
Rorc), te de to decrease Gsr (p = 0.06) and Sod2 (p = 0.07), and decreased Glut1 by 17% in healthy
mic (Figure 7A–C). Sin e MLN tissue is an important site of T cell differentiation and aronia feeding
modulated MLN expres ion of glutathione peroxidase during colitis, w eval ated mitochondrial
H2O2 by MitoB. Aronia feeding decreased the mitochondrial H2O2 in MLN by 29% relative to the
control diet (Figure 7D).
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of proinflammatory cytokines in the colon. Colitis was associated with oxidative stress in the colon 
indicated by increased MDA production, decreased GPx activity, and rGSH level. Aronia berry 
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Figure 7. Aronia consumption decreases mitochondria H2O2 in MLN but does not affect the expression
of antioxidant enzymes and cytokines in the spleen. C57BL/6J mice consumed the AIN-93M diet or
aronia-supplemented diet for five weeks. (A) The mRNA expressions of transcription factors of Foxp3
(forkhead box P3) and Rorc (RAR-related orphan receptor gamma), and cytokines of Il17a (interleukin
17A), Il6 (interleukin 6), Il10 (interleukin 10), Ifng (interferon-γ), and Tnf (tumor necrosis factors) in the
spleen (n = 5–7/group). (B) The mRNA expressions of transcription factor of Nfe2l2 (erythroid-derived
2-like 2) and the downstream antioxidant enzymes of Gclc (glutamate-cysteine ligase-catalytic subunit),
Gsr (glutathione reductase), Sod2 (superoxide dismutase 2), Gpx1 (glutathione peroxidase 1), Gpx2
(glutathione peroxidase 2), and Prdx1 (peroxiredoxin 1) in the spleen (n = 6–7/group). (C) The mRNA
expressions of Glut1 (glucose transporter 1) in the spleen (n = 6–7/group). (D) MitoP/MitoB ratio in
mesenteric lymph node (MLN) (n = 4–5/group). The mRNA expressions (normalized to Eef2 (eukaryotic
translation elongat on factor 2) and Rplp0 (ribosomal protei large P0)). Data are means ± SEMs.
4. Discussion
The T cell transfer model of colitis recapitulates the histopathological characteristics of human
IBD [23]. In this rodent model of colitis, aronia consumption modulated oxidative stress in the colon,
spleen, and MLN, tissues responsible for development of pro-inflammatory T cell populations. Aronia
berry consumption inhibited colitic weight loss and reduced intestinal inflammation evidenced by lower
colon weight/length ratios, reduced intestinal FDG uptake, and downregulation of proinflammatory
cytokines in the colon. Colitis was associated with oxidative stress in the colon indicated by increased
MDA production, decreased GPx activity, and rGSH level. Aronia berry consumption reduced the
oxidative stress at least partly by preventing colitis-associated downregulation of Nfe2l2 and antioxidant
enzymes in colon and MLN.
We previously demonstrated that aronia feeding inhibited pro-inflammatory colonic cytokines
and increased Th17 IL-10+ cells; however, colon histological markers were not affected [22].
Histopathological scores were based on a wide range of abnormalities such as degree of immunocytes
infiltration, occurrence of crypt exudate, crypt loss, and/or effacement, presence of neutrophils and
multinucleate giant cells, etc., which might have masked the ability to observe the anti-inflammatory
effects of aronia berries by histopathological evaluation during severe colitis [22]. Moreover, the
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adoptive transfer of T cells not only induces colonic inflammation, but also causes inflammatory
damage and injury in the small intestine, liver, and other organs [23]. Therefore, FDG bio-distribution
was determined in various tissues to evaluate tissue-specific inflammatory activity. FDG is an analog of
glucose which can be absorbed by cells through glucose transporters; unlike glucose, FDG cannot enter
glycolysis and is trapped intracellularly as FDG-6-phosphate [33]. In the presence of inflammation,
infiltration and activation of immune cells require increased glucose import primarily through GLUT1;
therefore, FDG bio-distribution could serve as a non-invasive biomarker for tissue inflammation [27].
Since FDG bio-distribution primarily depends on the extent of immunocyte activation rather than other
abnormalities in colitis, it may serve as a more effective technique to differentiate the anti-inflammatory
effects of the dietary intervention at the late stage of colitis. In this study, the colitic control group
had significantly higher FDG uptakes in the colon, cecum, and small intestine than non-colitic mice,
indicating inflammation in the intestinal tract; by contrast, aronia feeding significantly reduced FDG
uptake into tissues independent of modulation of glucose transporters. This is in accordance with our
previous finding that adoptive transfer induced increased infiltration of immune cells in the colon,
which were ameliorated by aronia supplementation [22]. Compared with colitic mice on control diet,
the aronia group had lower expressions of proinflammatory cytokines in the colon. This might partly
explain how aronia reduced adoptive transfer-induced production of proinflammatory cytokines in
the colon [22]. Interestingly, the cytokine expression did not mirror the changes in transcription factors
for Treg (FoxP3) and Th17 (ROR) cells differentiation in the colon as previously observed [22], although
Il17a and Il10 were increased in the MLN. The change in cytokines was more likely due to the extent
of CD4+ cells infiltrating the colon [22]. Moreover, we observed that aronia feeding also suppressed
FDG uptake in the spleen and lungs, demonstrating that the anti-inflammatory effect of aronia berry
consumption during T cell transfer colitis extends to organs outside the intestinal tract.
Loss of body weight and other symptoms of colitis (i.e., diarrhea or lose stool, reduced physical
activity) result from systemic production of effector T cells (Th17 and Th1) after the T cell transfer and
the interaction between effector T cells and gut microbiota [23,34]. Impaired absorption of nutrients
during colitis can be explained by changes in enterocyte functionality in the small intestine [35].
The progression of colitis depends on mouse genetics and the housing environment [23]. We have
consistently observed the onset of colitic weight loss beginning at four weeks after T cell transfer [22,36].
We previously showed that at seven weeks after adoptive transfer of T cells, mice developed severe
colitis as measured by histopathology and colonic cytokine production [22]. However, the protective
effect of aronia supplementation was diminished at this stage, suggesting a preventive rather than
therapeutic effect.
These results reinforce the relationship of oxidative stress and colitis, evidenced by depletion of
antioxidant enzymes and extent of oxidative damage. The rGSH and GPx activity in the colon was
significantly lower in the colitic mice than in the non-colitic mice; by contrast, aronia feeding preserved
rGSH which might also contribute to maintaining GPx activity. Gcl, the key enzyme involved in
GSH synthesis, was downregulated in MLN of colitic control but sustained by aronia consumption.
Similarly, decreased rGSH levels were found in both inflamed and non-inflamed mucosa in patients
with IBD, which was attributed to reduced GCL activity [37]. Moreover, MDA was increased in colitic
mice and reduced by aronia feeding. Similarly, MDA was elevated in the luminal epithelium of both
inflamed Crohn’s disease (CD) and the inflamed ulcerative colitis (UC) mucosa [38].
During intestinal inflammation, the major source of ROS is from infiltrated immune cells, such as
macrophages and neutrophils [10]. Aronia consumption inhibits myeloperoxidase (MPO) during T
cell transfer, an indicator that neutrophil infiltration is suppressed during colitis [22]. Superoxide is
produced in the cytosol by enzymes such as COX-2 and NADPH oxidase (NOX) and then converted
into H2O2 by CuZn-SOD [6]. These enzymes are regulated by Nrf2, which modulates the cellular
defense against oxidative insults within the intestinal epithelium and the lamina propria by induction
of antioxidant enzymes [2]. Nrf2 deficient mice were more susceptible to dextran sulfate sodium
(DSS)-induced colitis and developed much more severe symptoms than wild type mice, partly due to
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increased ROS production by COX-2 [39]. Nrf2 deficient mice also had greater LPS-induced pulmonary
inflammation and greater NOX-dependent ROS production [40]. On the other hand, increased
Nrf2 expression by enzymatically synthesized glycogen showed protective effects against DSS and
2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in C57BL/6 mice [41]. In this study, Nrf2
transcription was suppressed in MLN of colitic mice and several downstream antioxidant enzymes
were downregulated correspondingly. Aronia feeding was able to prevent the downregulation of
Nrf2 in the MLN and maintain the transcription of antioxidant enzymes. Similarly, in a DSS-induced
colitic mice model, peracetylated (-)-epigallocatechin-3-gallate abated colitis, partly by activation and
maintenance of Nrf2 and the downstream antioxidant enzymes [42]. Interestingly, the mRNA level
of Nrf2 in the colon was not affected by the T cell transfer, although the mRNA expression of SOD2
and Gpx1 was lowered by colitis but maintained by aronia feeding. Aronia may have modulated
Nrf2 protein concentration or nuclear translocation to affect the expression of downstream antioxidant
enzymes in the colon.
Another important source of ROS is mitochondria, in which superoxide is produced by the electron
transport chain during the respiratory process [6]. Mitochondrial ROS levels in mononuclear cells
were significantly higher in patients with IBD [43]. Moreover, dinitrophenol-induced mitochondrial
superoxide caused significant internalization and translocation of Escherichia coli across epithelia in
biopsy specimens in patients with CD [44]. However, mitochondria ROS is underestimated due to
lack of reliable quantification methods in vivo; a ratiometric mass spectrometry probe MitoB which
reacts with H2O2 and accumulates in mitochondria facilitates the measurement of mitochondrial H2O2
production in vivo [31]. In this study, mitochondrial H2O2 level, indicated by MitoP/MitoB ratios did
not differ in colons of the colitic and aronia groups, but was significantly lowered by aronia feeding
in the spleen corroborating reduced splenic FDG. The different effects of aronia supplementation on
mitochondrial H2O2 production in the spleen and colon during colitis could be explained by differences
in cell populations between these tissues. We cannot exclude the possibility that colonic epithelial cells
or immunocytes have altered mitochondrial H2O2 production after aronia consumptions, since we
evaluated MitoP/MitoB ratios in whole colon tissue. Indeed, anthocyanin and other berry polyphenols
can have direct effects on epithelial cells, which include inhibition of NF-κB, inhibiting cytokine
production, and improving barrier function [45]. Isolation of specific cell types from the colon and other
tissues requires additional time and processing, which may alter transient MitoP/MitoB distribution in
viable cells. Thus, other experimental approaches are needed to define the role of mitochondrial H2O2
in specific cell types during colitis.
These data are supported by the more robust modulation of antioxidant enzymes in the MLN
relative to the colon in response to aronia supplementation. Similarly, a mitochondrial-targeted
derivative of the antioxidant ubiquinone significantly ameliorated DSS-induced colitis by suppressing
mitochondrial injury [43]. Another mitochondria-targeted antioxidant, (2-(2,2,6,6-Tetramethylpiperidin-
1-oxyl-4-ylamino)-2-oxoethyl) triphenylphosphonium chloride inhibited the barrier defects and reduced
the severity of DSS-induced colitis [44]. Interestingly, we also showed that aronia feeding decreased
MLN mitochondrial H2O2 level in healthy wild-type mice. Because superoxide is produced by the
electron transport chain during the respiratory process under physiological conditions, aronia berry
reduces basal mitochondrial oxidative stress prior to the initiation of chronic intestinal inflammation.
Polyphenol-rich foods are protective in rodent models of colitis. In a DSS-induced colitis mice
model, orally administered blueberry extract attenuated the development of colitis, which was
associated with markedly attenuated colonic MPO activity, decreased MDA in the colon, increased
serum levels of SOD and catalase [15]. In a dinitrobenzene sulfonic acid (DNBS)-induced colitis
model, daily feeding of flavonoid-rich extract of orange juice decreased neutrophil infiltration, colonic
TNF-α and IL-1β generation, and nuclear NF-κB translocation, which were associated with decreased
nitrotyrosine and enhanced MnSOD expression [14]. These models are based on chemical erosion
and cannot recapitulate many histopathological characteristics of human IBD; by contrast, the T
cell adoptive transfer model induces intestinal inflammation that shares the same histopathological
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characteristics as human IBD [34]. Increasing evidence supports the anti-inflammatory effects of dietary
fiber in IBD. For example, Hung and Suzuki examined the effects of different doses of dietary fiber
supplementation (5% and 10%) in DSS-induced mice and found that 10% of dietary fiber reduced
intestinal barrier defects and inflammation [46]. Similarly, supplementation of 10% of pectin soluble
fiber attenuated clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice [47].
In this study, the fiber content in the control and aronia diets were ~5%–6% (w/w), which was lower
than the previously reported effective dose. Nevertheless, future work is warranted to examine the
potential synergistic effects between fiber and polyphenols in aronia berries.
In conclusion, we demonstrated that the antioxidant effects of aronia are multifaceted in the T cell
adoptive transfer model of colitis. Aronia feeding upregulated expression of antioxidant enzymes,
prevented colitis-induced depletion of rGSH, maintained GPx activity, and also targeted mitochondria
and reduced mitochondrial ROS production. These changes illustrate that antioxidant mechanisms
of aronia consumption during T cell transfer colitis are multi-faceted and tissue specific. This study
illustrates that the protective effects of aronia consumption during colitis are closely associated with
antioxidant and mitochondrial peroxide levels in immunocytes.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/6/1316/s1,
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the control (AIN-93M) or aronia-supplemented diets for three or five weeks. Histopathological scores of colons
were based on degree of inflammatory infiltration of the mucosa, submucosa, muscularis, and serosa, occurrence
of crypt exudate, crypt loss, and/or effacement, presence of neutrophils and multinucleate giant cells in the
inflammatory cell infiltrate, and ulceration. Total scores of 0 (unaffected) to 300 (severe, 100% of colon) were
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sequences of target and reference genes.
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